Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period. These subjects (3 atovaquone/proguanil recip...
Бүрэн тодорхойлолт
Номзүйн дэлгэрэнгүй
| Үндсэн зохиолчид: |
Lacy, MD,
Maguire, J,
Barcus, M,
Ling, J,
Bangs, M,
Gramzinski, R,
Basri, H,
Sismadi, P,
Miller, G,
Chulay, J,
Fryauff, D,
Hoffman, S,
Baird, J |
|---|
| Формат: | Journal article
|
|---|
| Хэл сонгох: | English |
|---|
| Хэвлэсэн: |
2002
|
|---|